Please login to the form below

Not currently logged in
Email:
Password:

Peter Goold and Colin White join Penn Pharma

Appointed to senior roles in supply chain team

Colin White - Penn PharmaPenn Pharma has appointed Peter Goold and Colin White (pictured) to senior positions in its supply chain team.

Peter Goold will take over the newly created role of director of supply chain and project management at the UK-based pharma services company, while Colin White has been appointed as head of manufacturing, running the production operation at Penn's UK facility.

Penn's chief executive, Dr Richard Yarwood said: “Peter and Colin join Penn at an integral point in the company's growth. Their strong technical backgrounds in their respective areas and vast customer service experience in outsourcing will be a great asset to the Penn brand.”

This growth includes the construction of new facilities due to open in 2013 that will boost the company's manufacturing efforts.

According to Penn, Goold and White have a combined 30 years of experience in the pharmaceutical and outsourcing industry, which has included running global supply chain operations covering commercial packing, solid oral dose manufacturing, and sterile products production.

Goold said: “It is fantastic to be joining Penn at such a momentous stage in the company's growth. The growth plans in place are a great motivation to ensure additional business is secured for our new contained manufacturing operation.”

22nd June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Black Swan Analysis

We are experts in pharmaceutical forecasting with access to proprietary databases of disease-specific patient populations. We understand the limits of...

Latest intelligence

Business as usual
MHRA explains that its emphasis will remain firmly on vetting when it comes to pharma advertising...
How to get management buy-in for content marketing
Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in...
EY Life Sciences Sector Update
Asia-Pacific and Japan...

Infographics